Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
Glycoprotein IIb/IIIa inhibitors are an adjuvant therapy for the treatment of patients with acute coronary syndromes. The main adverse reactions are bleeding and thrombocytopenia in 1–2% of cases. A 66-year-old woman arrived at the emergency department with ST-elevation MI. The catheterisation lab w...
Main Authors: | Gian-Manuel Jiménez-Rodríguez, Patricia Carmona-Levario, José-Alberto Ayón-Martínez, Aleksandra Gasecka, Luis Eduardo Juárez-Orozco, Antonio Reyes-Ortega, Patricia Espinosa-González, Gyna Alejandra Altamirano-Solorzano, Guering Eid-Lidt |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2023-04-01
|
Series: | Interventional Cardiology: Reviews, Research, Resources |
Online Access: | https://www.icrjournal.com/articleindex/icr.2022.23 |
Similar Items
-
Tirofiban-induced thrombocytopenia
by: Jun Wang, et al.
Published: (2023-12-01) -
Case report: reuse of tirofiban leads to very severe thrombocytopenia
by: Yuqing Li, et al.
Published: (2023-05-01) -
Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
by: Muhammad Shabbir Rawala, et al.
Published: (2020-03-01) -
Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
by: Ze-Mu Wang, et al.
Published: (2023-10-01) -
Local tirofiban infusion for remnant stenosis in large vessel occlusion: tirofiban ASSIST study
by: Yong-Won Kim, et al.
Published: (2020-07-01)